Jacqueline Brandwynne
Directeur Général chez Brandwynne Corp.
Profil
Ms. Jacqueline Brandwynne is President & Chief Executive Officer at Brandwynne Corp.
and an Advisor at Proteus Venture Partners LLC (Venture Capital).
She is on the Board of Directors at Cedars Sinai Health System and California Institute of the Arts.
Ms. Brandwynne was previously employed as Independent Director by ImmunoCellular Therapeutics Ltd.
She also served on the board at MicroVision, Inc. and Pacific Union Bank.
Postes actifs de Jacqueline Brandwynne
| Sociétés | Poste | Début |
|---|---|---|
| Brandwynne Corp. | Directeur Général | 22/02/2011 |
| California Institute of the Arts | Directeur/Membre du Conseil | 22/02/2011 |
Anciens postes connus de Jacqueline Brandwynne
| Sociétés | Poste | Fin |
|---|---|---|
| Pacific Union Bank (California) | Directeur/Membre du Conseil | 15/01/2013 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 24/09/2012 |
| MICROVISION, INC. | Directeur/Membre du Conseil | 28/02/2006 |
Cedars Sinai Health System
 Cedars Sinai Health System Hospital/Nursing ManagementHealth Services Cedars Sinai Health System provides patient care services. The firm offers healthcare services, biomedical research and education and training to physicians. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Directeur/Membre du Conseil | - |
Proteus RM LLC (Venture Capital)
 Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Consultant / Advisor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MICROVISION, INC. | Electronic Technology |
| Entreprise privées | 5 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
| Pacific Union Bank (California) | Finance |
Cedars Sinai Health System
Cedars Sinai Health System Hospital/Nursing ManagementHealth Services Cedars Sinai Health System provides patient care services. The firm offers healthcare services, biomedical research and education and training to physicians. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
| Brandwynne Corp. |
